Stock 603301 ZHENDE MEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Zhende Medical Co., Ltd.

Equities

603301

CNE100003J31

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
20.86 CNY +1.41% Intraday chart for Zhende Medical Co., Ltd. +3.94% -14.86%
04-26 Zhende Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Zhende Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 54% by 2026.
  • The company's profit outlook over the next few years is a strong asset.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

Weaknesses

  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ZHENDE MEDICAL CO., LTD. Stock Zhende Medical Co., Ltd.
-14.86% 764M -
COLOPLAST A/S Stock Coloplast A/S
+8.37% 27.03B
B+
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+14.77% 2.39B -
A-
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-51.12% 2.18B
B-
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-32.08% 2.03B
C+
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
+22.22% 1.87B
B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-18.71% 1.71B -
NAKANISHI INC. Stock Nakanishi Inc.
+7.63% 1.34B -
KOSSAN RUBBER INDUSTRIES Stock Kossan Rubber Industries
+27.03% 1.27B
C
GVS S.P.A. Stock GVS S.p.A.
+17.85% 1.23B
B
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 603301 Stock
  4. Ratings Zhende Medical Co., Ltd.